---
title: Biomay AG vs Creative Biogene
slug_a: biomay
slug_b: creative-biogene
site: cdmo
review_signal_gate: closed
canonical_path: /compare/biomay/creative-biogene
---

# Biomay AG vs Creative Biogene

Side-by-side profile data from each company listing on this directory.

## Biomay AG

- Profile: [/companies/biomay](/companies/biomay)

Biomay AG — GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (8).

### Services

- Recombinant Protein Manufacturing
- Cell-Line Development
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Gene Therapy

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Expression: Mammalian
- Expression: Microbial

## Creative Biogene

- Profile: [/companies/creative-biogene](/companies/creative-biogene)

Creative Biogene — Creative Biogene provides viral vector manufacturing, cell line development, and RNA therapeutic platforms including AAV, lentivirus, adenovirus production, circular RNA synthesis, and lipid nanoparticle formulation for gene therapy and vaccine applications.

Services: 11. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Vaccine Manufacturing
- CMC Analytical Development

### Modalities

- mRNA
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial